Carolina de la Cuesta, MD
Infectious Disease · Miami, FLNPI 1144421892
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Tetraphase Pharmaceuticals, Inc. at 59.9% of the total. Reporting peaked in 2019 at $3,609 and has fallen 96.4% since, to $130 in 2025.
Across 49 payments — averaging $120.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tetraphase Pharmaceuticals, Inc.$4K
- Edwards Lifesciences$1K
- AbbVie$294
- Hemosonics LLC$197
- Pfizer$130
- Atricure, Inc.$110
- plus $205 from 4 others
What the payments were for
- Speaking & faculty fees$3,12853%
- Travel & lodging$68812%
- Food & beverage$1,98334%
- Gifts$902%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tetraphase Pharmaceuticals, Inc. | 8 | $3,530 |
| Edwards Lifesciences | 12 | $1,423 |
| AbbVie | 11 | $294 |
| Hemosonics LLC | 3 | $197 |
| Pfizer | 6 | $130 |
| Atricure, Inc. | 1 | $110 |
| Johnson & Johnson(2 entities) | 3 | $79 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Vapotherm Inc | 2 | $51 |
| Shionogi Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,889 in reported general payments places this provider in the 80th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Miami
- Douglas BrustMiami$359K
- Dushyantha JayaweeraMiami$98K
- Ricardo FrancoMiami$96K
- Lilian AbboMiami$61K
- Jorge MurilloMiami$53K
- Thomas HootonMiami$42K
- Gilberto Torres-MadrizMiami$42K
- Vanessa SilebiMiami$32K
- Hector BolivarMiami$25K
- Jose Camargo GalvisMiami$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.